title: Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
authors.affiliation: Department of Haematology, Hinchingbrooke Hospital, Huntingdon.
authors.forename: Richard
authors.initials: R
authors.lastname: Dillon
authors.forename: Gideon M
authors.initials: GM
authors.lastname: Hirschfield
authors.forename: Michael E D
authors.initials: ME
authors.lastname: Allison
authors.forename: Kanchan P
authors.initials: KP
authors.lastname: Rege
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006515:Hepatitis B virus / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D017114:Liver Failure, Acute / Q000139:chemically induced*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D011241:Prednisone / Q000009:adverse effects; D000069283:Rituximab; D014750:Vincristine / Q000009:adverse effects; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000998:Antiviral Agents; D019259:Lamivudine; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone